Uploaded image for project: 'eCQM Issue Tracker'
  1. eCQM Issue Tracker
  2. CQM-6614

Question about VTE 1 and VTE 2

XMLWordPrintable

    • Icon: EC eCQMs - Eligible Clinicians EC eCQMs - Eligible Clinicians
    • Resolution: Answered
    • Icon: Moderate Moderate
    • None
    • None
    • Jessica Nelson
    • 16627205054
    • Hide
      Thank you for your question about CMS108 (VTE-1), Venous Thromboembolism Prophylaxis / CMS190 (VTE-2) Intensive Care Unit Venous Thromboembolism Prophylaxis.

      Rivaroxaban (Xarelto) administration is considered as a "Pharmacological VTE Prophylaxis Received" and will meet the numerator requirements. The corresponding value set for this criteria is "Rivaroxaban for VTE Prophylaxis" (2.16.840.1.113762.1.4.1110.50).

      For a patient who receives Apixaban (Eliquis) to meet the numerator requirement, there must be a prior or present diagnosis of atrial fibrillation OR prior diagnosis of VTE OR prior or present procedure of hip or knee replacement surgery to meet the numerator criteria. The corresponding value set for this criteria is "Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment" (2.16.840.1.113883.3.117.1.7.1.134).

      You can review the valuesets RXNORM codes in the VSAC https://vsac.nlm.nih.gov/.
      Show
      Thank you for your question about CMS108 (VTE-1), Venous Thromboembolism Prophylaxis / CMS190 (VTE-2) Intensive Care Unit Venous Thromboembolism Prophylaxis. Rivaroxaban (Xarelto) administration is considered as a "Pharmacological VTE Prophylaxis Received" and will meet the numerator requirements. The corresponding value set for this criteria is "Rivaroxaban for VTE Prophylaxis" (2.16.840.1.113762.1.4.1110.50). For a patient who receives Apixaban (Eliquis) to meet the numerator requirement, there must be a prior or present diagnosis of atrial fibrillation OR prior diagnosis of VTE OR prior or present procedure of hip or knee replacement surgery to meet the numerator criteria. The corresponding value set for this criteria is "Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment" (2.16.840.1.113883.3.117.1.7.1.134). You can review the valuesets RXNORM codes in the VSAC https://vsac.nlm.nih.gov/ .
    • Not measure related
    • CMS1056v1
    • CMS1206v1
    • Not measure related
    • CMS0002v13
    • Not measure related
    • Not measure related
    • CMS0002v12
    • Not measure related
    • Meeting measures

      Will Eloquis and Xarelto continue to meet the measure in 2024?

      Thanks

       

      I do not know what to put in all the boxes below, so I apologize if I selected the wrong one.

            JLeflore Joelencia Leflore
            Jnelson40 Jessica Nelson (Inactive)
            Votes:
            0 Vote for this issue
            Watchers:
            2 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: